Primary Care Annual Subject Index 2004

[ Subject | Author ]

Aging
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Depression in the female geriatric patient. Jun(suppl):19-22
Driving safety and the elderly woman: considerations for the primary care physician. Jun(suppl):7-13
Infections in older women. Jun(suppl):30-37
Insomnia. Jun(suppl):14-18
Lifetime approach to osteoporosis. Jun(suppl):23-29
Minimizing loss. Jun(suppl):6

back to top

Alternative medicine
Nonprescription options for high-density lipoprotein cholesterol therapy in postmenopausal women. Sep:11-18
Nutritional influences on osteoporosis. Jul:38-42

back to top

Autoimmune disorders
New developments in the treatment of psoriasis: beginnings of the biologic era. Jun:10-14

back to top

Cancer
Cancer, sexuality, and sexual expression. Mar:21-24
Cervical cancer screening: revised guidelines. Dec:36-44
Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:34-40
Olivia Newton-John, breast cancer activist. Aug(suppl):4-6
Progestogen in hormone therapy: recommendations for individualizing therapy. Apr:47-48
The Women’s Health Initiative reports: critical review of the findings. Oct:35-41

back to top

Cardiovascular disorders
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Cardiovascular disease in women: prevention and screening. Aug:34-43
Nonprescription options for high-density lipoprotein cholesterol therapy in postmenopausal women. Sep:11-18
Overview of lipid therapy in women. Feb:9-18
Recognizing prodromal symptoms in women at risk for coronary heart disease. Aug:10-14
The Women’s Health Initiative reports: critical review of the findings. Oct:35-41

back to top

Continuing medical education (CME)
Acne in women. Nov:10-18 [test 51-52]
Evaluating psychological problems: is it clinical depression? Oct:8-12 [test 8-12]
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Dec:17-22 [test 45-46]
Irritable bowel syndrome: new perspectives on treatment. Mar:10-16 [test 49-50]
Nonprescription options for high-density lipoprotein cholesterol therapy in postmenopausal women. Sep:11-18 [test 55-56]
Overview of lipid therapy in women. Feb:9-18 [test 47-48]
Pregnancy, contraception, and epilepsy: what are the risks? Apr:10-13,29 [test 49-50]
Recognizing prodromal symptoms in women at risk for coronary heart disease. Aug:10-14 [test 47-48]
Sex-steroid hormones in women with epilepsy. Jul:23-29 [test 47-48]
A targeted approach to musculoskeletal pain, part 1: mechanisms and diagnosis. May:9-13 [test 47-48]
A targeted approach to musculoskeletal pain, part 2: management and pharmacotherapy. Jun:22-28 [test 41-42]
Update on vaccinations for women. Jan:12-18 [test 45-46]

back to top

Contraception and contraceptives
Beyond forty: do contraceptive needs change? Apr:37-38
Contraceptive safety from a global perspective: the 2004 WHO medical eligibility criteria for contraception. Jun:39-40
Emergency contraception: telling the secret. Nov:19-24,33
Forty and fabulous: do contraceptive needs change? Aug(suppl):21-22
Four hypotheses for understanding menstrual migraine. May:38-42
Insurance coverage and reproductive health options. Aug:31-33
Intrauterine contraception: time for a comeback. Jul:16-22
Pregnancy, contraception, and epilepsy: what are the risks? Apr:10-13,29
Pregnancy testing: a “teachable moment”. Dec:43-44,51

back to top

Dermatologic disorders
Acne in women. Nov:10-18
Infections in older women. Jun(suppl):30-37
New developments in the treatment of psoriasis: beginnings of the biologic era. Jun:10-14

back to top

Diabetes
Cardiovascular disease in women: prevention and screening. Aug:34-43
Screening for type 2 diabetes in primary care. Sep:27-29,52

back to top

Domestic abuse
Detecting domestic violence: to screen or not to screen? Apr:39-44
Domestic violence screening. Jul:10
Intimate partner abuse and its health implications. Feb:19-28,46

back to top

Editorials
The annual physical examination and its implications. Jun:9
Caring for the mature woman—here we go again. Sep:10
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
Domestic violence screening. Jul:10
How do we read the medical literature? Jan:8,11
Improving patient compliance through education. Mar:8-9
Liability tort reform: not a done deal. Aug:8-9
Minimizing loss. Jun(suppl):6
The most prevalent chronic disease in America. Apr:8-9,44
The physician as a risk manager. May:8
Physician's time: the neglected health care resource. Oct:6-7
WANTED: Effective patient education. Feb:7-8
You are a statistic (but probably don't know it!). Dec:7-8

back to top

Exercise
From perimenopause to postmenopause: two case studies. Sep:19-24
Nonprescription options for high-density lipoprotein cholesterol therapy in postmenopausal women. Sep:11-18

back to top

Gastrointestinal disorders
Infections in older women. Jun(suppl):30-37
Irritable bowel syndrome: the evolving perspective. Dec:23-31
Irritable bowel syndrome: new perspectives on treatment. Mar:10-16

back to top

Genetics
Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:34-40
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:15-19

back to top

Gynecologic disorders
Cervical cancer screening: Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:34-40
Dyspareunia: a systematic approach to diagnosis. Mar:42-46
Endometrial evaluation: assessing perimenopausal and postmenopausal women. Nov:47-49
Endometriosis, part 1: diagnosis and evaluation. Feb:38-43
Endometriosis, part 2: treatment options. Mar:25-33,46
Practical evaluation of the incontinent woman. Apr:30-36
Uterine fibroids and sexual dysfunction: true, true, and related? May:33-36

back to top

Headache
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
Four hypotheses for understanding menstrual migraine. May:38-42
Hormonally associated migraine. Jul:30-36

back to top

Hormones and hormone therapy
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Cardiovascular disease in women: prevention and screening. Aug:34-43
Caring for the mature woman—here we go again. Sep:10
Effects of hormone supplementation on mood in women. Oct:31-34
Estrogen and cognition. Nov:26-28
Four hypotheses for understanding menstrual migraine. May:38-42
From perimenopause to postmenopause: two case studies. Sep:19-24
Hormonally associated migraine. Jul:30-36
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Dec:17-22
NAMS publishes hormone therapy recommendations. Feb:44-46
Osteoporosis: options for prevention and treatment. Aug:20-30
Parathyroid hormone: a new development in the treatment of osteoporosis. Dec(suppl):1-12
Postmenopausal androgen therapy. Nov:40-46
Premature natural menopause: women with special needs. Aug(suppl):7-8
Premature ovarian failure: women with special needs. Aug:45-46
Progestogen in hormone therapy: recommendations for individualizing therapy. Apr:47-48
Sex-steroid hormones in women with epilepsy. Jul:23-29
Use of conjugated estrogens after the women’s health initiative. Jun:29-37
Using estradiol cream to improve quality of life in women with overactive bladder. Feb:29-36
The Women’s Health Initiative reports: critical review of the findings. Oct:35-41

back to top

Infections
Infections in older women. Jun(suppl):30-37

back to top

Menopause
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Caring for the mature woman—here we go again. Sep:10
Effects of hormone supplementation on mood in women. Oct:31-34
Endometrial evaluation: assessing perimenopausal and postmenopausal women. Nov:47-49
Estrogen and cognition. Nov:26-28
From perimenopause to postmenopause: two case studies. Sep:19-24
Hormonally associated migraine. Jul:30-36
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Dec:17-22
Lifetime approach to osteoporosis. Jun(suppl):23-29
NAMS publishes hormone therapy recommendations. Feb:44-46
Nonprescription options for high-density lipoprotein cholesterol therapy in postmenopausal women. Sep:11-18
Nutritional influences on osteoporosis. Jul:38-42
Osteoporosis: preventing it is a lifelong pursuit. Aug(suppl):9-12
Parathyroid hormone: a new development in the treatment of osteoporosis. Dec(suppl):1-12
Postmenopausal androgen therapy. Nov:40-46
Premature natural menopause: women with special needs. Aug(suppl):7-8
Premature ovarian failure: women with special needs. Aug:45-46
Progestogen in hormone therapy: recommendations for individualizing therapy. Apr:47-48
Sex-steroid hormones in women with epilepsy. Jul:23-29
Use of conjugated estrogens after the women’s health initiative. Jun:29-37
Using estradiol cream to improve quality of life in women with overactive bladder. Feb:29-36
The Women’s Health Initiative reports: critical review of the findings. Oct:35-41

back to top

Menstruation
Four hypotheses for understanding menstrual migraine. May:38-42
Hormonally associated migraine. Jul:30-36
Intrauterine contraception: time for a comeback. Jul:16-22
Safety evaluation of modern feminine hygiene pads: two decades of use. Oct:23-30
Sex-steroid hormones in women with epilepsy. Jul:23-29 [test 47-48]
Special concerns in caring for the female athlete. Jul:11-15

back to top

Musculoskeletal disorders
Chronic pelvic pain: the myofascial component. Dec:9-16
A targeted approach to musculoskeletal pain, part 1: mechanisms and diagnosis. May:9-13
A targeted approach to musculoskeletal pain, part 2: management and pharmacotherapy. Jun:22-28

back to top

Neurologic disorders
Diagnosis and treatment of attention-deficit/hyperactivity disorder in women. Nov:29-33
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Dec:17-22
Pregnancy, contraception, and epilepsy: what are the risks? Apr:10-13,29 [test 49-50]
Sex-steroid hormones in women with epilepsy. Jul:23-29 [test 47-48]

back to top

Nutrition
From perimenopause to postmenopause: two case studies. Sep:19-24
Nonprescription options for high-density lipoprotein cholesterol therapy in postmenopausal women. Sep:11-18
Nutritional influences on osteoporosis. Jul:38-42
Osteoporosis: preventing it is a lifelong pursuit. Aug(suppl):9-12
Special concerns in caring for the female athlete. Jul:11-15

back to top

Obesity
Cardiovascular disease in women: prevention and screening. Aug:34-43
Childhood sexual abuse and its psychological correlates in the obese female patient. Jan:23-27
The most prevalent chronic disease in America. Apr:8-9,44
Surgical options in the treatment of severe obesity. Sep:30-42

back to top

Obstetrics and gynecology
Amnioinfusion. Jan:38-43
Caring for the mature woman—here we go again. Sep:10
Lights, camera, (legal) action: videotaping in the delivery room. May:25-30
Pregnancy testing: a “teachable moment”. Dec:43-44,51
You are a statistic (but probably don't know it!). Dec:7-8

back to top

Osteoporosis
From perimenopause to postmenopause: two case studies. Sep:19-24
Lifetime approach to osteoporosis. Jun(suppl):23-29
Nutritional influences on osteoporosis. Jul:38-42
Osteoporosis and the statin agents. Oct:13-20
Osteoporosis: options for prevention and treatment. Aug:20-30
Osteoporosis: preventing it is a lifelong pursuit. Aug(suppl):9-12
Parathyroid hormone: a new development in the treatment of osteoporosis. Dec(suppl):1-12
The Women’s Health Initiative reports: critical review of the findings. Oct:35-41

back to top

Pain
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
Chronic pelvic pain: the myofascial component. Dec:9-16
Dyspareunia: a systematic approach to diagnosis. Mar:42-46
Endometriosis, part 1: diagnosis and evaluation. Feb:38-43
Endometriosis, part 2: treatment options. Mar:25-33,46
Hormonally associated migraine. Jul:30-36
Interstitial cystitis. Apr:22-29
A targeted approach to musculoskeletal pain, part 1: mechanisms and diagnosis. May:9-13
A targeted approach to musculoskeletal pain, part 2: management and pharmacotherapy. Jun:22-28

back to top

Patient education
6 things you might want to know about polycystic ovary syndrome. Aug(suppl):23
8 things you might want to know about contraception. Apr(suppl):9
Anxiety disorders. Aug(suppl):15-17
At every age, at every stage, women need calcium. Feb(suppl):17-19
The bone mineral density test. Apr(suppl):23
Emergency contraception. Feb(suppl):14-16
Endometriosis: a common condition that can be treated. Apr(suppl):10-11,15-16
Forty and fabulous: do contraceptive needs change? Aug(suppl):21-22
Heart disease: an ounce of prevention… Feb(suppl):4-8
Hemorrhoids: no laughing matter. Aug(suppl):18-20
Migraine and the workplace: sufferers are less productive. Apr(suppl):4-6
Olivia Newton-John, breast cancer activist. Aug(suppl):4-6
Osteoporosis: preventing it is a lifelong pursuit. Aug(suppl):9-12
Premature natural menopause: women with special needs. Aug(suppl):7-8
Progestogen: the other menopausal hormone. Apr(suppl):21-22
Rheumatoid arthritis. Feb(suppl):9-11
When hormone therapy makes sense. Feb(suppl):12-13
Will I lose my breast? Apr(suppl):17-20

What you should know about…

Acne. Nov:53-54
Adult immunizations. Jan:47-48
Depression. Oct:47-48
Diabetes. Sep:57-58
Endometriosis. Mar:51-52
Keeping your heart healthy. Feb:49-50
Nutrition and osteoporosis. Jul:49-50
Pain relief. May:45-46
Pap smears. Dec:47-48
Psoriasis. Jun:43-44
Recognizing and preventing heart attacks. Aug:49-50
Social anxiety disorder. Apr:51-52

back to top

Pharmacotherapy
Acne in women. Nov:10-18
Detection and management of postpartum depression. Nov:34-39,49
Diagnosis and treatment of attention-deficit/hyperactivity disorder in women. Nov:29-33
Endometriosis, part 2: treatment options. Mar:25-33,46
From perimenopause to postmenopause: two case studies. Sep:19-24
Hormonally associated migraine. Jul:30-36
Hypoactive sexual desire disorder in the reproductive-aged woman. Sep:44-52
Insomnia. Jun(suppl):14-18
Irritable bowel syndrome: new perspectives on treatment. Mar:10-16
New developments in the treatment of psoriasis: beginnings of the biologic era. Jun:10-14
Osteoporosis and the statin agents. Oct:13-20
Osteoporosis: options for prevention and treatment. Aug:20-30
Osteoporosis: preventing it is a lifelong pursuit. Aug(suppl):9-12
Overview of lipid therapy in women. Feb:9-18
Parathyroid hormone: a new development in the treatment of osteoporosis. Dec(suppl):1-12
Selective serotonin reuptake inhibitors and sexual dysfunction in women. May:14-22
A targeted approach to musculoskeletal pain, part 1: mechanisms and diagnosis. May:9-13
A targeted approach to musculoskeletal pain, part 2: management and pharmacotherapy. Jun:22-28

back to top

Pregnancy
Amnioinfusion. Jan:38-43
Beyond forty: do contraceptive needs change? Apr:37-38
Forty and fabulous: do contraceptive needs change? Aug(suppl):21-22
Hormonally associated migraine. Jul:30-36
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:15-19
Preconception screening and counseling. Oct:42-45
Pregnancy, contraception, and epilepsy: what are the risks? Apr:10-13,29
Pregnancy outcome in motor vehicle accidents. Jan:28-35
Pregnancy testing: a “teachable moment”. Dec:43-44,51
Update on vaccinations for women. Jan:12-18
Up-to-date immunizations: an important part of prenatal care. Dec:32-36

back to top

Prenatal screening
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:15-19
Up-to-date immunizations: an important part of prenatal care. Dec:32-36

back to top

Preventive medicine
Cardiovascular disease in women: prevention and screening. Aug:34-43
Hemorrhoids: no laughing matter. Aug(suppl):18-20
Osteoporosis: options for prevention and treatment. Aug:20-30
Update on vaccinations for women. Jan:12-18
Up-to-date immunizations: an important part of prenatal care. Dec:32-36

back to top

Psychiatric disorders
Anxiety disorders. Aug(suppl):15-17
Cardiovascular disease in women: prevention and screening. Aug:34-43
Childhood sexual abuse and its psychological correlates in the obese female patient. Jan:23-27
Depression in the female geriatric patient. Jun(suppl):19-22
Detection and management of postpartum depression. Nov:34-39,49
Effects of hormone supplementation on mood in women. Oct:31-34
Evaluating psychological problems: is it clinical depression? Oct:8-12
Selective serotonin reuptake inhibitors and sexual dysfunction in women. May:14-22
Social anxiety disorder. Apr:14-16,21

back to top

Psychological issues
Cancer, sexuality, and sexual expression. Mar:21-24
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
Childhood sexual abuse and its psychological correlates in the obese female patient. Jan:23-27
Hypoactive sexual desire disorder in the reproductive-aged woman. Sep:44-52
Intimate partner abuse and its health implications. Feb:19-28,46

back to top

Pulmonary disorders
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:15-19

back to top

Regulatory issues
Insurance coverage and reproductive health options. Aug:31-33
Liability tort reform: not a done deal. Aug:8-9

back to top

Respiratory disorders
Infections in older women. Jun(suppl):30-37

back to top

Screening
Cardiovascular disease in women: prevention and screening. Aug:34-43
Cervical cancer screening: revised guidelines. Dec:36-44
Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:34-40
Detecting domestic violence: to screen or not to screen? Apr:39-44
Domestic violence screening. Jul:10
Endometrial evaluation: assessing perimenopausal and postmenopausal women. Nov:47-49
Evaluating psychological problems: is it clinical depression? Oct:8-12
Intimate partner abuse and its health implications. Feb:19-28,46
Overview of lipid therapy in women. Feb:9-18
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:15-19
Preconception screening and counseling. Oct:42-45
Recognizing prodromal symptoms in women at risk for coronary heart disease. Aug:10-14
Screening for type 2 diabetes in primary care. Sep:27-29,52

back to top

Sexual abuse/assault
Childhood sexual abuse and its psychological correlates in the obese female patient. Jan:23-27
Expert witness testimony in sexual assault. Jun:16-21
Intimate partner abuse and its health implications. Feb:19-28,46

back to top

Sexual health
Cancer, sexuality, and sexual expression. Mar:21-24
Dyspareunia: a systematic approach to diagnosis. Mar:42-46
Female sexual dysfunction in primary care: when is referral to a sex therapist indicated? Jul:43-45
Hypoactive sexual desire disorder in the reproductive-aged woman. Sep:44-52
Postmenopausal androgen therapy. Nov:40-46
Selective serotonin reuptake inhibitors and sexual dysfunction in women. May:14-22
Sex with oneself. Jan:36-37,43
Uterine fibroids and sexual dysfunction: true, true, and related? May:33-36

back to top

Surgery
Endometriosis, part 2: treatment options. Mar:25-33,46
Hemorrhoids: no laughing matter. Aug(suppl):18-20
Surgical options in the treatment of severe obesity. Sep:30-42
You are a statistic (but probably don't know it!). Dec:7-8

back to top

Urologic disorders
Infections in older women. Jun(suppl):30-37
Interstitial cystitis. Apr:22-29
Practical evaluation of the incontinent woman. Apr:30-36
Using estradiol cream to improve quality of life in women with overactive bladder. Feb:29-36

back to top